These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37612850)

  • 1. Hyperuricemia and Gout: The Role of Losartan.
    Saad M
    Sr Care Pharm; 2023 Sep; 38(9):359-360. PubMed ID: 37612850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Other antihyperuricemic agents].
    Ogino K; Igawa O; Hisatome I
    Nihon Rinsho; 2008 Apr; 66(4):754-7. PubMed ID: 18409527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uric acid-lowering effect of dotinurad, a novel selective urate reabsorption inhibitor, in hypertensive patients with gout or asymptomatic hyperuricemia: a pooled analysis of individual participant data in phase II and III trials.
    Takahashi T; Beppu T; Hidaka Y; Hosoya T
    Clin Exp Hypertens; 2021 Nov; 43(8):730-741. PubMed ID: 34425059
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative efficacy and safety of uricosuric agents in the treatment of gout or hyperuricemia: a systematic review and network meta-analysis.
    Li YJ; Chen LR; Yang ZL; Wang P; Jiang FF; Guo Y; Qian K; Yang M; Yin SJ; He GH
    Clin Rheumatol; 2023 Jan; 42(1):215-224. PubMed ID: 36036279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricaemia and gout.
    Würzner G; Gerster JC; Chiolero A; Maillard M; Fallab-Stubi CL; Brunner HR; Burnier M
    J Hypertens; 2001 Oct; 19(10):1855-60. PubMed ID: 11593107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. URAT1 gene polymorphisms influence uricosuric action of losartan in hypertensive patients with hyperuricemia.
    Sun H; Qu Q; Qu J; Lou XY; Peng Y; Zeng Y; Wang G
    Pharmacogenomics; 2015 Jul; 16(8):855-63. PubMed ID: 26086348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Gout and cardiovascular risk].
    Němec P
    Vnitr Lek; 2014 Oct; 60(10):893-901. PubMed ID: 25382012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lozartan potential in hyperuricemia correction].
    Ter Arkh; 2011; 83(10):45-8. PubMed ID: 22185025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of combination treatment using anti-hyperuricaemic agents with fenofibrate and/or losartan on uric acid metabolism.
    Takahashi S; Moriwaki Y; Yamamoto T; Tsutsumi Z; Ka T; Fukuchi M
    Ann Rheum Dis; 2003 Jun; 62(6):572-5. PubMed ID: 12759298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current and future therapeutic options for the management of gout.
    Whelton A
    Am J Ther; 2010; 17(4):402-17. PubMed ID: 20562597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uric acid: role in cardiovascular disease and effects of losartan.
    Alderman M; Aiyer KJ
    Curr Med Res Opin; 2004 Mar; 20(3):369-79. PubMed ID: 15025846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hyperuricemia. When and how to treat?].
    Reuss-Borst MA
    Internist (Berl); 2016 Feb; 57(2):194-201. PubMed ID: 26791735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertension, its treatment, hyperuricaemia and gout.
    Gibson TJ
    Curr Opin Rheumatol; 2013 Mar; 25(2):217-22. PubMed ID: 23370375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Losartan-induced angioedema.
    Rivera JO
    Ann Pharmacother; 1999 Sep; 33(9):933-5. PubMed ID: 10492493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High- versus low-dose losartan and uric acid: An analysis from HEAAL.
    Ferreira JP; Zannad F; Kiernan MS; Konstam MA
    J Cardiol; 2023 Jul; 82(1):57-61. PubMed ID: 37030532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of losartan in hypertensive patients with thiazide-induced hyperuricemia.
    Shahinfar S; Simpson RL; Carides AD; Thiyagarajan B; Nakagawa Y; Umans JG; Parks JH; Coe FL
    Kidney Int; 1999 Nov; 56(5):1879-85. PubMed ID: 10571797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Losartan treatment for hypertensive patients with hyperuricaemia in Chinese population: a meta-analysis.
    Fan Y; Wei F; Lang Y; Wang S
    J Hypertens; 2015 Apr; 33(4):681-8; discussion 689. PubMed ID: 25915869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial effect of switching from a combination of angiotensin II receptor blockers other than losartan and thiazides to a fixed dose of losartan/hydrochlorothiazide on uric acid metabolism in hypertensive patients.
    Ohshiro K; Sakima A; Nakada S; Kohagura K; Yamazato M; Tana T; Ohya Y
    Clin Exp Hypertens; 2011; 33(8):565-70. PubMed ID: 21958001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of angiotensin II receptor blockers on hyperuricemia.
    Wolff ML; Cruz JL; Vanderman AJ; Brown JN
    Ther Adv Chronic Dis; 2015 Nov; 6(6):339-46. PubMed ID: 26568810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metoprolol Increases Uric Acid and Risk of Gout in African Americans With Chronic Kidney Disease Attributed to Hypertension.
    Juraschek SP; Appel LJ; Miller ER
    Am J Hypertens; 2017 Sep; 30(9):871-875. PubMed ID: 28830083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.